source
- Merck highlights oncology pipeline and cancer vaccine trial at ESMO 2026Merck attended the European Society for Medical Oncology (ESMO) meeting in Madrid, using the conference to present updates on its oncology portfolio. Media coverage largely centered on the company…
- Aspen Neuroscience and Bambusa Therapeutics each aim for $135 million IPOsAspen Neuroscience announced plans to raise about $135 million through an initial public offering, proposing to sell roughly 9.38 million shares. Bambusa Therapeutics also filed for an IPO targeti…